Bloomberg News

Three to Watch: BMY, QSFT, AOL

June 25, 2012

The FDA does not approve Bristol Meyers' pill Eliquis, Quest gets a new offer and AOL considers share repurchase

The Aging of Abercrombie & Fitch
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus